Imada N, Kawauchi A, Kitamori T, Ohne T, Tanaka Y, Watanabe H
Department of Urology, Kyoto Prefectural University of Medicine.
Nihon Hinyokika Gakkai Zasshi. 1996 Sep;87(9):1114-9. doi: 10.5980/jpnjurol1989.87.1114.
The long-term results of systematic treatment based on overnight simultaneous monitoring of electroencephalography (EEG) and cystometry in the patients with enuresis were evaluated.
From January to December a total of 213 patients were classified into 3 types. Enuresis Type I: such cases show a normal cystometrogram (CMG) with an awakening response on the EEG before enuresis, but they do not awake. Enuresis Type IIa; such cases show a normal CMG without an awakening response on the EEG. Enuresis Type IIb: such cases show an abnormal CMG with no awakening response on the EEG. When such cases enter the deep sleep stage, continuous uninhibited contractions of the bladder are observed on the CMG. 136 cases were of Type I, 20 cases of Type IIa, and 57 cases of Type IIb.
Out of 213 patients who were followed up for 2 years, cured cases were 94 (44%), effective cases were 81 (38%) and unchanged cases were 38 (18%). In 136 patients with Type I, cured cases were 71 (52%), effective cases were 50 (37%) and unchanged cases were 15 (11%). In 20 patients with Type IIa, cured cases were 8 (40%), effective cases were 9 (45%) and unchanged cases were 3 (15%). In 57 patients with Type IIb, cured cases were 15 (26%), effective cases were 22 (39%) and unchanged cases were 20 (35%). The age of the effective group, which included cured cases and effective cases, was significantly higher than that of the unchanged group. In enuresis Type I, the percentage of the patients with incontinence in daytime were significantly in the unchanged group than in the effective group. No significant differences in the frequency of enuresis and the percentage of the patients who had awakened spontaneously by urinary sensation were found between the two groups.
The therapeutic response was best in enuresis Type 1 and worst in enuresis Type IIb. The patients, in whom not only frequency of enuresis but also type of enuresis was unchanged by systematic treatment for two years, was approximately 10% across the types. Accordingly they were thought to be non-responders to this systematic treatment.
评估基于夜间同步监测脑电图(EEG)和膀胱测压对遗尿症患者进行系统治疗的长期效果。
1月至12月,共213例患者被分为3种类型。遗尿症I型:此类病例膀胱测压图(CMG)正常,遗尿前EEG有觉醒反应,但未觉醒。遗尿症IIa型:此类病例CMG正常,EEG无觉醒反应。遗尿症IIb型:此类病例CMG异常,EEG无觉醒反应。当此类病例进入深睡眠阶段时,CMG上观察到膀胱持续无抑制收缩。I型136例,IIa型20例,IIb型57例。
213例患者随访2年,治愈94例(44%),有效81例(38%),无效38例(18%)。136例I型患者中,治愈71例(52%),有效50例(37%),无效15例(11%)。20例IIa型患者中,治愈8例(40%),有效9例(45%),无效3例(15%)。57例IIb型患者中,治愈15例(26%),有效22例(39%),无效20例(35%)。包括治愈病例和有效病例的有效组年龄显著高于无效组。在遗尿症I型中,无效组白天失禁患者的百分比显著高于有效组。两组间遗尿频率及因尿意自发觉醒患者的百分比无显著差异。
遗尿症I型治疗反应最佳,IIb型最差。经过两年系统治疗,遗尿频率和类型均未改变的患者在各类型中约占10%。因此,他们被认为对此系统治疗无反应。